Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Putative azithromycin resistance mutations in Chlamydia trachomatis are globally distributed but arose before azithromycin was discovered.

  • Read more about Putative azithromycin resistance mutations in Chlamydia trachomatis are globally distributed but arose before azithromycin was discovered.

Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.

  • Read more about Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.

Targeting Alpha Toxin To Mitigate Its Lethal Toxicity in Ferret and Rabbit Models of Staphylococcus aureus Necrotizing Pneumonia.

  • Read more about Targeting Alpha Toxin To Mitigate Its Lethal Toxicity in Ferret and Rabbit Models of Staphylococcus aureus Necrotizing Pneumonia.

Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections.

  • Read more about Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections.

Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.

  • Read more about Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.

Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.

  • Read more about Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.

In vitro activity of antiretroviral drugs against Plasmodium falciparum.

  • Read more about In vitro activity of antiretroviral drugs against Plasmodium falciparum.

Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.

  • Read more about Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.

Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women.

  • Read more about Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women.

Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children.

  • Read more about Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children.
Subscribe to Antimicrobial agents and chemotherapy

Pediatrics Home

MAKE A GIFT

© 2026 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                   Accessibility  Privacy Policy  Terms of Use  A-Z Website List